The U.S. Food and Drug Administration today approved Dovato (dolutegravir and lamivudine), as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults with no antiretroviral treatment history and with no known or suspected substitutions associated with resistance to the individual components of Dovato. This is the first FDA-approved two-drug, fixed-dose, complete regimen for HIV-infected adults who have never received treatment for HIV. Read More
Reading Time: < 1 minute They are the third most commonly used form of contraception in the UK, behind the Pill and the hormonal implant, official data…
Reading Time: < 1 minute An increasing number of people catching the sexually transmitted infection are finding it does not respond to antibiotics. Read More
Reading Time: < 1 minute Sexually transmitted infections (STIs) and reproductive tract infections (RTIs) are major global health issues, impacting quality of life, causing infertility, cancers, and…
Subscribe to our Blog
Let's stay in touch. Subscribe to our blog and get our best content in your inbox.
